For CBFB-MYH11 AMLs, fusion breakpoint location 21 nearly reached significance in prediction of EFS within our training cohort (Supplementary Fig. 11 ) and reached significance within our previously published results when the CBFB-MYH11 AML cohort was analyzed in aggregate 43 .
← all excerpts
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
1
—
—